Report Overview

The China dermatology therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The Sexagenarian population of china counts to nearly 30.7 percentage of their entire population and to cater this aging population dermatological care is likely to receive particular attention. The Asia-pacific registered the highest CAGR of 12.3% in the world geography and China alone register a major market share in the dermatology therapeutics.



Market Drivers

The unprecedented growth rate of market size of dermatology segment along with increased personal spending, increased geriatric population, growing awareness about skin diseases, increased incidence of dermatology diseases, strong pipeline of dermatology products and increasing use of anti-aging products are the key factors boosting the growth of dermatology drugs. Other secondary drivers which contribute to the growth of dermatology drugs are rising beauty consciousness and a demand for non-invasive cosmetics repair treatments.

The major factors which contributes to skin problems among Chinese population is the stress or lack of sleep. However expensive dermatology treatments, stringent regulatory policies & side effects linked to dermatology diagnosis contributes to restricting the market growth for the dermatology drugs in china.